Genetic systems for studying obligate intracellular pathogens: An update

Current Opinion in Microbiology

Volumn 17, Issue 1, 2014, Pages 11-16

  Wood, David O ^a   Wood, Raphael R ^a   Tucker, Aimee M ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASMA; BACTERIAL VIRULENCE; CELL GROWTH; CHLAMYDIA; COXIELLA; EHRLICHIA; GENETIC ANALYSIS; GENETIC MANIPULATION; GENETIC PROCEDURES; GENETICS; GENUS; INTRACELLULAR BACTERIUM; NONHUMAN; OBLIGATE INTRACELLULAR BACTERIAL PATHOGEN; ORIENTIA; REVIEW; RICKETTSIA;

ANAPLASMA; BACTERIOLOGICAL TECHNIQUES; CHLAMYDIA; GENETIC TECHNIQUES; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INTRACELLULAR SPACE; RICKETTSIA;

EID: 84889688729     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2013.10.006     Document Type: Review

References (38)

1. Omsland A., Cockrell D.C., Howe D., Fischer E.R., Virtaneva K., Sturdevant D.E., Porcella S.F., Heinzen R.A. Host cell-free growth of the Q fever bacterium Coxiella burnetii. Proc Natl Acad Sci USA 2009, 106:4430-4434.
2. Beare P.A., Sandoz K.M., Omsland A., Rockey D.D., Heinzen R.A. Advances in genetic manipulation of obligate intracellular bacterial pathogens. Front Microbiol 2011, 2:97.
3. Silva M.T. Classical labeling of bacterial pathogens according to their lifestyle in the host: inconsistencies and alternatives. Front Microbiol 2012, 3:71.
4. Rikihisa Y. Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum. Clin Microbiol Rev 2011, 24:469-489.
5. Pierle S.A., Hammac G.K., Palmer G.H., Brayton K.A. Transcriptional pathways associated with the slow growth phenotype of transformed Anaplasma marginale. BMC Genomics 2013, 14:272.
6. Centers for Disease Control and Prevention: Chlamydia-Fact Sheet. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/std/chlamydia/stdfact-chlamydia.htm.
7. Rockey D., Valdivia R. A new dawn for chlamydia research. Microbe Magazine 2012, vol September. American Society for Microbiology (Ed.).
8. Kari L., Goheen M.M., Randall L.B., Taylor L.D., Carlson J.H., Whitmire W.M., Virok D., Rajaram K., Endresz V., McClarty G., et al. Generation of targeted Chlamydia trachomatis null mutants. Proc Natl Acad Sci USA 2011, 108:7189-7193.
9. Nguyen B.D., Valdivia R.H. Virulence determinants in the obligate intracellular pathogen Chlamydia trachomatis revealed by forward genetic approaches. Proc Natl Acad Sci USA 2012, 109:1263-1268.
10. DeMars R., Weinfurter J. Interstrain gene transfer in Chlamydia trachomatis in vitro: mechanism and significance. J Bacteriol 2008, 190:1605-1614.
11. Jeffrey B.M., Suchland R.J., Eriksen S.G., Sandoz K.M., Rockey D.D. Genomic and phenotypic characterization of in vitro-generated Chlamydia trachomatis recombinants. BMC Microbiol 2013, 13:142.
12. Tam J.E., Davis C.H., Wyrick P.B. Expression of recombinant DNA introduced into Chlamydia trachomatis by electroporation. Can J Microbiol 1994, 40:583-591.
13. Hudson A.P. A major advance in elucidating the biology/pathobiology of Chlamydia trachomatis. Infect Immun 2013, 81:622-624.
14. Wang Y., Kahane S., Cutcliffe L.T., Skilton R.J., Lambden P.R., Clarke I.N. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog 2011, 7:e1002258.
15. Wang Y., Cutcliffe L.T., Skilton R.J., Persson K., Bjartling C., Clarke I.N. Transformation of a plasmid-free, genital tract isolate of Chlamydia trachomatis with a plasmid vector carrying a deletion in CDS6 revealed that this gene regulates inclusion phenotype. Pathog Dis 2013, 67:100-103.
16. Wang Y., Kahane S., Cutcliffe L.T., Skilton R.J., Lambden P.R., Persson K., Bjartling C., Clarke I.N. Genetic transformation of a clinical (genital tract), plasmid-free isolate of Chlamydia trachomatis: engineering the plasmid as a cloning vector. PLoS One 2013, 8:e59195.
17. Song L., Carlson J.H., Whitmire W.M., Kari L., Virtaneva K., Sturdevant D.E., Watkins H., Zhou B., Sturdevant G.L., Porcella S.F., et al. Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional regulator of virulence-associated genes. Infect Immun 2013, 81:636-644.
18. Gerard H.C., Mishra M.K., Mao G., Wang S., Hali M., Whittum-Hudson J.A., Kannan R.M., Hudson A.P. Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae. Nanomedicine: NBM 2013, xx:1-13.
19. Mishra M.K., Gerard H.C., Whittum-Hudson J.A., Hudson A.P., Kannan R.M. Dendrimer-enabled modulation of gene expression in Chlamydia trachomatis. Mol Pharm 2012, 9:413-421.
20. Omsland A., Sager J., Nair V., Sturdevant D.E., Hackstadt T. Developmental stage-specific metabolic and transcriptional activity of Chlamydia trachomatis in an axenic medium. Proc Natl Acad Sci USA 2012, 109:19781-19785.
21. Omsland A., Heinzen R.A. Life on the outside: the rescue of Coxiella burnetii from its host cell. Annu Rev Microbiol 2011, 65:111-128.
22. Beare P.A. Genetic manipulation of Coxiella burnetii. Adv Exp Med Biol 2012, 984:249-271.
23. Beare P.A., Larson C.L., Gilk S.D., Heinzen R.A. Two systems for targeted gene deletion in Coxiella burnetii. Appl Environ Microbiol 2012, 78:4580-4589.
24. Cheng C., Nair A.D., Indukuri V.V., Gong S., Felsheim R.F., Jaworski D., Munderloh U.G., Ganta R.R. Targeted and random mutagenesis of Ehrlichia chaffeensis for the identification of genes required for in vivo infection. PLoS Pathog 2013, 9:e1003171.
25. Rapsang A.G., Bhattacharyya P. Scrub typhus. J Indian Anaesth 2013, 57:127-134.
26. Nakayama K., Yamashita A., Kurokawa K., Morimoto T., Ogawa M., Fukuhara M., Urakami H., Ohnishi M., Uchiyama I., Ogura Y., et al. The Whole-genome sequencing of the obligate intracellular bacterium Orientia tsutsugamushi revealed massive gene amplification during reductive genome evolution. DNA Res 2008, 15:185-199.
27. Cho N.H., Kim H.R., Lee J.H., Kim S.Y., Kim J., Cha S., Kim S.Y., Darby A.C., Fuxelius H.H., Yin J., et al. The Orientia tsutsugamushi genome reveals massive proliferation of conjugative type IV secretion system and host-cell interaction genes. Proc Natl Acad Sci USA 2007, 104:7981-7986.
28. Duong V., Blassdell K., May T.T., Sreyrath L., Gavotte L., Morand S., Frutos R., Buchy P. Diversity of Orientia tsutsugamushi clinical isolates in Cambodia reveals active selection and recombination process. Infect Genet Evol 2013, 15:25-34.
29. Clark T.R., Ellison D.W., Kleba B., Hackstadt T. Complementation of Rickettsia rickettsii RelA/SpoT restores a nonlytic plaque phenotype. Infect Immun 2011, 79:1631-1637.
30. Clark T.R., Lackey A.M., Kleba B., Driskell L.O., Lutter E.I., Martens C., Wood D.O., Hackstadt T. Transformation frequency of a mariner-based transposon in Rickettsia rickettsii. J Bacteriol 2011, 193:4993-4995.
31. Welch M.D., Reed S.C., Lamason R.L., Serio A.W. Expression of an epitope-tagged virulence protein in Rickettsia parkeri using transposon insertion. PLoS One 2012, 7:e37310.
32. Liu Z.-M., Tucker A.M., Driskell L.O., Wood D.O. Mariner-based transposon mutagenesis of Rickettsia prowazekii. Appl Environ Microbiol 2007, 73:6644-6649.
33. Burkhardt N.Y., Baldridge G.D., Williamson P.C., Billingsley P.M., Heu C.C., Felsheim R.F., Kurtti T.J., Munderloh U.G. Development of shuttle vectors for transformation of diverse Rickettsia species. PLoS One 2011, 6:e29511.
34. Wood D.O., Hines A., Tucker A.M., Woodard A., Driskell L.O., Burkhardt N.Y., Kurtti T.J., Baldridge G.D., Munderloh U.G. Establishment of a replicating plasmid in Rickettsia prowazekii. PLoS One 2012, 7:e34715.
35. Rachek L.I., Hines A., Tucker A.M., Winkler H.H., Wood D.O. Transformation of Rickettsia prowazekii to erythromycin resistance encoded by the Escherichia coli ereB gene. J Bacteriol 2000, 182:3289-3291.
36. Madeira da Silva L., Owens K.L., Murta S.M., Beverley S.M. Regulated expression of the Leishmania major surface virulence factor lipophosphoglycan using conditionally destabilized fusion proteins. Proc Natl Acad Sci USA 2009, 106:7583-7588.
37. Bikard D., Jiang W., Samai P., Hochschild A., Zhang F., Marraffini L.A. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res 2013, 41:7429-7437.
38. Richter H., Randau L., Plagens A. Exploiting CRISPR/Cas: interference mechanisms and applications. Int J Mol Sci 2013, 14:14518-14531.